"OCT provides ultra-high resolution images of the vessel lumen and structural detail not seen before by other imaging modalities," continued Lussier. "With OCT, physicians will be able to visualize structures in the lumen and the adjacent vessel wall down to a resolution of approximately 15 microns. We believe the high resolution images that OCT provides along with the wider field of view, image depth, and plaque characterization that IVUS delivers will complement each other as physicians focus on lesion assessment and therapy guidance."
"After achieving CE Mark approval and completing successful clinical trials in multiple countries, we are excited to build on our success and add OCT to Volcano's integrated multi-modality platform," added Lussier. "We believe that there is no single tool that will be best for every physician, every patient, or even every lesion. We currently provide five interventional tools and plan to double the number of modalities on our system in the coming years."
Dr. Alex Abizaid from the Dante Pazzanese Cardiology Institute in Sao Paulo, Brazil, said, "The Volcano OCT system provides fantastic images and is easy to use. With these OCT images, I can assess thrombus, lesion cap thickness, tissue growth on previously deployed stents and stent apposition at the time of implant. This is another great tool in addition to IVUS and FFR to help me augment angiography."
|SOURCE Volcano Corporation|
Copyright©2010 PR Newswire.
All rights reserved